XML 21 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK BASED COMPENSATION (Details 4) (Stock Options, USD $)
6 Months Ended
Jun. 30, 2014
Number of Options outstanding  
Granted (in shares) 376,500
Outstanding at the end of the reporting period (in shares) 376,500
Number of Options Exercisable  
Vested (in shares) 106,891
Exercisable at the end of the reporting period (in shares) 106,891
Weighted Average Exercise Price  
Granted, options outstanding (in dollars per share) $ 6.00
Outstanding at the end of the reporting period (in dollars per share) $ 6.00
Vested, options exercisable (in dollars per share) $ 6.00
Exercisable at the end of the reporting period (in dollars per share) $ 6.00
Weighted Average Grant Date Fair Value  
Options granted (in dollars per share) $ 4.01
Outstanding at the end of the reporting period (in dollars per share) $ 4.01
Vested, options exercisable (in dollars per share) $ 4.01
Exercisable at the end of the reporting period (in dollars per share) $ 4.01
Weighted Average Remaining Life In Years  
Granted 9 years 10 months 28 days
Outstanding at the end of the reporting period 9 years 10 months 28 days
Exercisable at the end of the reporting period 9 years 10 months 28 days
Value  
Granted $ 1,525,415
Outstanding at the end of the reporting period 1,525,415
Vested 461,576
Exercisable at the end of the reporting period $ 461,576
$6.00
 
Number of Options outstanding  
Outstanding at the end of the reporting period (in shares) 364,000
Number of Options Exercisable  
Exercisable at the end of the reporting period (in shares) 106,891
Weighted Average Exercise Price  
Outstanding at the end of the reporting period (in dollars per share) $ 6.00
Weighted Average Remaining Life In Years  
Exercisable at the end of the reporting period 9 years 10 months 28 days
$7.20
 
Number of Options outstanding  
Outstanding at the end of the reporting period (in shares) 12,500
Weighted Average Exercise Price  
Outstanding at the end of the reporting period (in dollars per share) $ 7.20
Weighted Average Remaining Life In Years  
Exercisable at the end of the reporting period 10 years